Good morning. From the rising number of early holiday decorations out, it's clear that folks are..
It's the monthly jobs numbers today and they're not going to be pretty and will be possibly the tip of the iceberg as we head into May.
| You're receiving this email because you are subscribed to Trading Tips, if you no longer wish to receive these emails you can unsubscribe here. | | | | |
| | | | DOW 29,591.27 | +1.12% | | | | S&P 3,577.60 | +0.56% | | | | NASDAQ 11,880.63 | +0.22% | | | | *As of market close | | • | Stocks rallied on Monday, on a third Covid vaccine and the unofficial start of the holidays. | | • | Oil rallied 1.2 percent, closing at $42.94 per barrel. | | • | Gold declined 2 percent, sliding to $1,833 per ounce. | | • | Cryptocurrencies traded mixed, with Bitcoin last changing hands at $18,343. | | | | | | | | Why One Mall-Based Retailer May Rally from Here | | | | Retail companies have had a tough year. Big-box stores and companies in the e-commerce space have zoomed ahead of other players. Companies that rely on in-store sales and foot traffic, such as stores at malls, have fallen by the wayside. Yet with earnings season underway, and with the economy trending up again, a few names in the mall-based space are starting to look attractive. One bank even brazenly upgraded one such name right before it reported earnings!
» FULL STORY | | | | | | Insider Trading Report: Bryn Mawr Bank (BMTC) | | | | Michael LaPlante, Chief Accounting Officer at Bryn Mawr Bank (BMTC) recently picked up 1,500 shares. That represented his initial purchase of company shares. The buy came to just over $45,000. This follows on a buy the day before from the company CFO, who picked up 3,000 shares. That increased his stake to over 18,230 shares, and came to a price of just over $91,000. Insider data shows that insiders have only been buyers in the past year. » FULL STORY | | | | | | Unusual Options Activity: Bed Bath & Beyond (BBBY) | | | | At least one trader is betting on a rally in Bed Bath & Beyond (BBBY) around the Black Friday holiday. That's based on the December 4th $21 call option. Expiring in 10 days, the option saw over 6,850 contracts trade against a prior open interest of 214, for a 32-fold rise in volume. The buyer of the calls paid about $0.84 per contract. With shares just over $21, this is an at-the-money trade. The buyer will make a profit as long as shares are over $21.84 on December 4th.
» FULL STORY | | | | | | | TOP | | OXY | 16.827% | | | M | 15.028% | | | APA | 12.413% | | | FANG | 11.672% | | | EOG | 10.994% | | | BOTTOM | | NEM | 4.818% | | | MKTX | 4.803% | | | CTLT | 3.416% | | | STE | 3.353% | | | WST | 3.164% | | | | | | | | | With three vaccines now showing efficacy at 90%+ and health officials in the U.S. and EU rushing to approve them, the vaccination process is set to commence before the end of the year. This vaccine optimism is more than offsetting the very grim near-term transmission/mitigation landscape as cases spike and governments take further action to curb the virus spread. | | - Adam Crisafulli of Vital Knowledge, on why the markets are heading higher even as Covid cases rise and renewed lockdowns have emerged in some hotspots. | | |
No comments:
Post a Comment